OmniAb (OABI) Shares Outstanding (Weighted Average) (2021 - 2026)

OmniAb (OABI) reported Shares Outstanding (Weighted Average) of $128.2 million for Q1 2026, up 21.42% year-over-year from $105.6 million in Q1 2025, and up 12.86% quarter-over-quarter from $113.6 million in Q4 2025.

OmniAb (OABI) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $128.2 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $128.2 million, up 21.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $128.2 million (up 21.42% YoY), and the FY2025 annual result was $113.6 million, up 11.01% from the prior year.
  • Shares Outstanding (Weighted Average) rose to $128.2 million in Q1 2026 per OABI's latest filing, from $113.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $128.2 million in Q1 2026 and troughed at $82.6 million in Q1 2022.
  • A 5-year average of $100.0 million and a median of $100.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) soared 1637.27% in 2022, then climbed 1.61% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $85.3 million in 2022, then climbed by 16.84% to $99.7 million in 2023, then increased by 2.69% to $102.4 million in 2024, then rose by 11.01% to $113.6 million in 2025, then increased by 12.86% to $128.2 million in 2026.
  • Business Quant data shows OABI's Shares Outstanding (Weighted Average) at $128.2 million in Q1 2026, $113.6 million in Q4 2025, and $108.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 128.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 128.25 Mn
Dec 31, 2025 113.64 Mn
Sep 30, 2025 108.87 Mn
Jun 30, 2025 105.89 Mn
Mar 31, 2025 105.62 Mn
Dec 31, 2024 102.37 Mn
Sep 30, 2024 102.39 Mn
Jun 30, 2024 101.46 Mn
Mar 31, 2024 100.76 Mn
Dec 31, 2023 99.68 Mn
Sep 30, 2023 99.91 Mn
Jun 30, 2023 99.49 Mn
Mar 31, 2023 99.16 Mn
Dec 31, 2022 85.32 Mn
Sep 30, 2022 82.61 Mn
Jun 30, 2022 82.61 Mn
Mar 31, 2022 82.61 Mn
Dec 31, 2021 82.61 Mn
Sep 30, 2021 4.76 Mn
Jun 30, 2021 5.00 Mn